NORTHWEST HEALTHCARE PROPERTIES REAL ESTATE INVESTMENT TRUST

Cash flow NorthWest Healthcare Properties Real Estate Investment Trust

Equities

NWH.UN

CA6674951059

Specialized REITs

Market Closed - Toronto S.E. Other stock markets 04:00:00 2025-12-08 pm EST			5-day change	1st Jan Change
5.240 ^CAD	-0.95%		-2.06%	+17.75%

Nov. 19	NorthWest Healthcare Properties Real Estate Investment Trust announces Monthly dividend, payable on December 15, 2025	CI
Dec. 05	NorthWest Healthcare Properties Real Estate Investment Trust, Q3 2025 Earnings Call, Nov 12, 2025

342e8e3.Bj1vOsNQaM_KiJ0iZU_KAgf9DtCwGZJbGrZj10xWmeA.SgteYq4BGpWD2vVHCx_-bne7Y5H7V78CfYIsrQkO6JFEaAgPnD4SvqTH_g

Published financial data: NORTHWEST HEALTHCARE PROPERTIES REAL ESTATE INVESTMENT TRUST

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Rental Revenues	374M	375M	449M	508M	462M
Property Management Fee	11.67M	16.54M	11.48M	15.36M	15.15M
Interest and Investment Income, Total (Revenue Block)	1.95M	4.6M	9.18M	18.56M	18.84M
Other Revenues, Total	52.09M	107M	20.6M	-19.23M	-30.72M
Total Revenues	440M	503M	490M	523M	466M
Property Expenses	88.02M	85.09M	100M	121M	113M
Selling General & Admin Expenses, Total	29.44M	40.2M	47.87M	57.57M	54.37M
Stock-Based Compensation (IS)	1.67M	2.67M	-10.24M	-10.81M	-3.69M
Other Operating Expenses	-	-909K	-316K	-	-
Total Operating Expenses	119M	127M	138M	168M	164M
Operating Income (REIT / Utility Template)	320M	376M	352M	355M	302M
Interest Expense, Total	-120M	-66.7M	-108M	-262M	-213M
Net Interest Expenses	-120M	-66.7M	-108M	-262M	-213M
Currency Exchange Gains (Loss)	-20.51M	14.74M	9.26M	-2.51M	33.93M
Other Non Operating Income (Expenses)	-5.26M	-56.76M	-14.78M	-13.07M	-68.56M
EBT, Excl. Unusual Items	175M	267M	239M	76.71M	54.25M
Restructuring Charges	-	-	-	-	-3.81M
Total Merger & Related Restructuring Charges	-28.63M	-37.98M	-28.36M	-50.98M	-16.69M
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	-	-34.67M
Asset Writedown	174M	514M	-28.8M	-572M	-369M
Other Unusual Items	-3.97M	-3.99M	17.2M	40.67M	-
EBT, Incl. Unusual Items	316M	739M	199M	-505M	-370M
Income Tax Expense	14.82M	124M	79.3M	-18.29M	-49.51M
Earnings From Continuing Operations	302M	615M	120M	-487M	-320M
Earnings Of Discontinued Operations	-	51.35M	-	-	-
Net Income to Company	302M	667M	120M	-487M	-320M
Minority Interest	-67.06M	-228M	-61.33M	133M	20.45M
Net Income - (IS)	235M	438M	58.33M	-354M	-300M
Net Income to Common Incl Extra Items	235M	438M	58.33M	-354M	-300M
Net Income to Common Excl. Extra Items	235M	387M	58.33M	-354M	-300M
Per Share Items
Net EPS - Basic	1.33	1.96	0.24	-1.46	-1.21
Basic EPS - Continuing Operations	1.33	1.73	0.24	-1.46	-1.21
Basic Weighted Average Shares Outstanding	176M	224M	241M	243M	248M
Net EPS - Diluted	1.33	1.96	0.24	-1.46	-1.21
Diluted EPS - Continuing Operations	1.33	1.73	0.24	-1.46	-1.21
Diluted Weighted Average Shares Outstanding	176M	224M	241M	243M	248M
Normalized Basic EPS	0.24	-0.27	0.37	0.74	0.22
Normalized Diluted EPS	0.24	-0.27	0.37	0.74	0.22
Dividend Per Share	0.8	0.8	0.8	0.65	0.36
Payout Ratio	55.41	31.11	265.3	-42.02	-26.16
Supplemental Items
EBITDA	322M	378M	354M	356M	306M
EBITA	320M	376M	352M	355M	302M
EBIT	320M	376M	352M	355M	302M
Effective Tax Rate - (Ratio)	4.68	16.8	39.86	3.62	13.39
Current Domestic Taxes	-	-	-	-	-
Current Foreign Taxes	-	-	-	-	-
Total Current Taxes	20.47M	13.2M	21.85M	26.97M	21.14M
Deferred Foreign Taxes	-	-	-	-	-
Total Deferred Taxes	-5.64M	111M	57.45M	-45.26M	-70.65M
Normalized Net Income	42.07M	-61.14M	87.99M	181M	54.35M
Interest Capitalized	3.66M	6.54M	10.06M	23.32M	23.44M
Interest on Long-Term Debt	112M	109M	169M	260M	237M
Supplemental Operating Expense Items
General and Administrative Expenses	29.44M	40.2M	47.87M	57.57M	54.37M
Stock-Based Comp., G&A Exp. (Total)	7.37M	8.98M	15.22M	6.68M	4.46M
Stock-Based Comp., Other (Total)	1.67M	2.67M	-10.24M	-10.81M	-3.69M
Total Stock-Based Compensation	9.05M	11.65M	4.99M	-4.13M	776K

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Net Property Plant And Equipment	5.27B	6.3B	6.62B	6.88B	5.26B
Total Real Estate Assets	5.27B	6.3B	6.62B	6.88B	5.26B
Cash And Equivalents	144M	62.74M	88.03M	72.03M	51.25M
Accounts Receivable, Total	9.65M	51.14M	17.38M	21.8M	15.21M
Other Receivables	3.83M	5.26M	4.15M	5.03M	17.82M
Investment In Debt and Equity Securities	-	100M	224M	76.77M	174M
Goodwill	41.67M	41.67M	39.61M	38.57M	37.18M
Other Intangibles, Total	47.31M	47.28M	44.97M	43.78M	47.69M
Notes Receivable (Collected)	10.92M	10.26M	10.27M	12.12M	14.96M
Restricted Cash	-	-	-	60K	1.73M
Other Current Assets, Total	6.43M	22.05M	988M	63.83M	69.45M
Trading Asset Securities, Total	-	510K	37.57M	25.86M	16.08M
Deferred Tax Assets Long-Term (Collected)	-	11.37M	14.15M	9.18M	2.45M
Other Long-Term Assets, Total	313M	411M	424M	377M	338M
Total Assets	5.85B	7.06B	8.51B	7.63B	6.05B
Liabilities
Current Portion of Long-Term Debt	903M	1.07B	1.62B	338M	349M
Current Portion of Leases	1.58M	1.72M	1.92M	2.17M	3.83M
Long-Term Debt	1.96B	1.91B	2.07B	3.58B	2.65B
Long-Term Leases	10.81M	11M	11.01M	12.2M	17.68M
Accounts Payable, Total	91.54M	89.76M	133M	129M	105M
Accrued Expenses, Total	24.28M	26.22M	23.94M	15.16M	9.93M
Current Income Taxes Payable	21.22M	11.38M	15.81M	21.44M	10.18M
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	12.53M	34.85M	444M	25.79M	7.48M
Unearned Revenue Non Current	-	-	-	-	-
Deferred Tax Liability Non-Current	288M	386M	458M	418M	315M
Total Liabilities	3.31B	3.54B	4.77B	4.54B	3.47B
Common Stock, Total	1.69B	2.29B	2.5B	2.53B	2.55B
Additional Paid In Capital	39.72M	39.72M	39.72M	39.72M	39.72M
Retained Earnings	85.34M	354M	229M	-	440M
Distributions In Excess Of Earnings	-	-	-	-277M	-1.11B
Comprehensive Income and Other	-181M	-292M	-316M	-293M	-358M
Total Common Equity	1.64B	2.39B	2.46B	1.99B	1.56B
Minority Interest	897M	1.13B	1.29B	1.09B	1.02B
Total Equity	2.54B	3.52B	3.74B	3.09B	2.58B
Total Liabilities And Equity	5.85B	7.06B	8.51B	7.63B	6.05B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	176M	224M	241M	243M	248M
ECS Total Common Shares Outstanding	176M	224M	241M	243M	248M
Book Value / Share	9.31	10.67	10.21	8.2	6.31
Tangible Book Value	1.55B	2.3B	2.37B	1.91B	1.48B
Tangible Book Value Per Share	8.8	10.28	9.86	7.86	5.97
Total Debt	2.87B	2.99B	3.7B	3.93B	3.02B
Net Debt	2.73B	2.93B	3.57B	3.84B	2.95B
Minority Interest, Total (Incl. Fin. Div)	897M	1.13B	1.29B	1.09B	1.02B
Equity Method Investments, Total	298M	381M	395M	362M	326M
Account Code - Inventory Valuation	3	3	3	3	3
Full Time Employees	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	1.28M	1.41M	2.43M	1.72M	2.04M

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	235M	438M	58.33M	-354M	-300M
Depreciation, Depletion & Amortization	1.58M	1.38M	1.4M	1.27M	3.67M
Total Depreciation, Depletion & Amortization	1.58M	1.38M	1.4M	1.27M	3.67M
Amortization of Deferred Charges, Total	11.05M	12.19M	10.7M	19.07M	22.66M
(Gain) Loss On Sale of Asset - (CF)	-91K	-	-	-	34.67M
(Gain) Loss on Sale of Investments - (CF)	-	-	-	18.5M	7.51M
Total Asset Writedown	-174M	-514M	28.8M	572M	369M
(Income) Loss On Equity Investments - (CF)	-52.09M	-107M	-20.6M	19.23M	30.72M
Stock-Based Compensation (CF)	6.83M	3.78M	-4.58M	-5.7M	776K
Change in Accounts Receivable	2.13M	-36.82M	26.83M	-13.58M	1.79M
Change in Accounts Payable	18.73M	21M	18.9M	5.65M	-6.24M
Change in Other Net Operating Assets (Collected)	8.26M	-3.85M	8.85M	5.7M	-2.38M
Other Operating Activities	132M	310M	95.56M	-163M	-75.57M
Cash from Operations	189M	125M	224M	105M	86.64M
Acquisition of Real Estate Assets, Total	-975M	-775M	-1.23B	-274M	-186M
Sale of Real Estate Assets, Total	194M	56.58M	7.07M	357M	455M
Net Sale / Acquisition of Real Estate Assets	-781M	-718M	-1.22B	83.19M	268M
Cash Acquisitions	-	-2.02M	-	-	-
Divestitures	198M	-	-	-	207M
Investment in Marketable and Equity Securities, Total	872K	-139M	-117M	153M	64.16M
Other Investing Activities, Total	-46.95M	-55.29M	-21.79M	-41.86M	676K
Cash from Investing	-629M	-915M	-1.36B	194M	540M
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	1.53B	1.57B	2.46B	907M	533M
Total Debt Issued	1.53B	1.57B	2.46B	907M	533M
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-1.08B	-1.19B	-1.38B	-1.03B	-1.06B
Total Debt Repaid	-1.08B	-1.19B	-1.38B	-1.03B	-1.06B
Issuance of Common Stock	122M	428M	179M	-	-
Repurchase of Common Stock	-7.2M	-	-	-	-
Common Dividends Paid	-130M	-136M	-155M	-149M	-78.43M
Common & Preferred Stock Dividends Paid	-130M	-136M	-155M	-149M	-78.43M
Other Financing Activities, Total	-38.48M	39.09M	72.03M	-43.15M	-47.36M
Cash from Financing	398M	711M	1.18B	-319M	-651M
Foreign Exchange Rate Adjustments	-5.88M	-2.72M	-19.14M	3.52M	3M
Net Change in Cash	-48.04M	-81.41M	25.29M	-15.96M	-20.84M
Supplemental Items
Cash Interest Paid	106M	97.1M	136M	228M	191M
Cash Income Tax Paid (Refund)	26.77M	26.29M	17.83M	22.36M	28.94M
Net Debt Issued / Repaid	451M	381M	1.08B	-127M	-525M
Levered Free Cash Flow	291M	173M	-307M	565M	16.93M
Unlevered Free Cash Flow	355M	202M	-250M	710M	127M
Change In Net Working Capital	-144M	45.21M	476M	-491M	64.84M

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	3.52	3.64	2.83	2.75	2.76
Return on Total Capital	3.82	3.94	3.16	3.07	2.99
Return On Equity %	13.08	20.31	3.29	-14.27	-11.3
Return on Common Equity	15.86	19.2	2.41	-15.91	-16.85
Margin Analysis
Gross Profit Margin %	79.97	83.09	79.5	76.78	75.73
SG&A Margin	6.7	7.99	9.77	11.01	11.68
EBITDA Margin %	73.25	75.03	72.17	68.08	65.64
EBITA Margin %	72.89	74.75	71.88	67.83	64.85
EBIT Margin %	72.89	74.75	71.88	67.83	64.85
Income From Continuing Operations Margin %	68.62	122.26	24.42	-93.19	-68.76
Net Income Margin %	53.36	87.09	11.9	-67.73	-64.37
Net Avail. For Common Margin %	53.36	76.89	11.9	-67.73	-64.37
Normalized Net Income Margin	9.57	-12.15	17.95	34.63	11.67
Levered Free Cash Flow Margin	66.1	34.37	-62.67	108.1	3.64
Unlevered Free Cash Flow Margin	80.66	40.23	-51.1	135.81	27.37
Asset Turnover
Asset Turnover	0.08	0.08	0.06	0.06	0.07
Fixed Assets Turnover	0.09	0.09	0.08	0.08	0.08
Receivables Turnover (Average Receivables)	26.3	12.87	13.44	26.71	25.81
Short Term Liquidity
Current Ratio	0.17	0.12	0.51	0.38	0.38
Quick Ratio	0.15	0.1	0.07	0.23	0.21
Operating Cash Flow to Current Liabilities	0.18	0.1	0.1	0.2	0.18
Days Sales Outstanding (Average Receivables)	13.91	28.36	27.17	13.66	14.18
Average Days Payable Outstanding	380.05	388.84	404.81	394.03	373.57
Long Term Solvency
Total Debt/Equity	113.27	84.92	98.81	127.5	116.99
Total Debt / Total Capital	53.11	45.92	49.7	56.04	53.92
LT Debt/Equity	77.59	54.46	55.51	116.47	103.33
Long-Term Debt / Total Capital	36.38	29.45	27.92	51.19	47.62
Total Liabilities / Total Assets	56.62	50.12	56.05	59.56	57.33
EBIT / Interest Expense	2.67	5.64	3.27	1.35	1.42
EBITDA / Interest Expense	2.68	5.66	3.28	1.36	1.43
(EBITDA - Capex) / Interest Expense	2.68	5.65	3.27	1.36	1.43
Total Debt / EBITDA	8.92	7.93	10.45	11.06	9.88
Net Debt / EBITDA	8.47	7.76	10.1	10.78	9.66
Total Debt / (EBITDA - Capex)	8.93	7.94	10.47	11.06	9.91
Net Debt / (EBITDA - Capex)	8.48	7.77	10.12	10.78	9.69
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	19.81	14.5	-2.61	5.92	-10.91
Gross Profit, 1 Yr. Growth %	25.7	18.96	-6.82	3	-12.12
EBITDA, 1 Yr. Growth %	32.75	17.27	-6.32	0.6	-14.1
EBITA, 1 Yr. Growth %	32.42	17.41	-6.35	0.64	-14.82
EBIT, 1 Yr. Growth %	32.42	17.41	-6.35	0.64	-14.82
Earnings From Cont. Operations, 1 Yr. Growth %	130.57	104	-80.55	-507.06	-33.39
Net Income, 1 Yr. Growth %	321.21	86.88	-86.69	-706.98	-13.79
Diluted EPS Before Extra, 1 Yr. Growth %	267.71	29.54	-85.96	-700.38	-15.35
Normalized Net Income, 1 Yr. Growth %	-329.09	-245.35	-243.9	105.7	-74.16
Net Property, Plant and Equip., 1 Yr. Growth %	6.74	19.6	5.09	3.94	-23.48
Accounts Receivable, 1 Yr. Growth %	-50.91	429.81	-66.01	25.42	-30.25
Total Assets, 1 Yr. Growth %	5.6	20.86	20.52	-10.4	-20.7
Common Equity, 1 Yr. Growth %	24.19	46	2.71	-18.83	-21.61
Tangible Book Value, 1 Yr. Growth %	25.93	48.65	3	-19.4	-22.67
Cash From Operations, 1 Yr. Growth %	46.77	-33.8	79.39	-54.17	-17.3
Capital Expenditures, 1 Yr. Growth %	-37.93	106.41	27.33	-84.07	800
Levered Free Cash Flow, 1 Yr. Growth %	86.88	-40.47	-273.97	-288.25	-97.01
Unlevered Free Cash Flow, 1 Yr. Growth %	43.16	-42.89	-221.54	-383.39	-81.79
Dividend Per Share, 1 Yr. Growth %	0	0	0	-18.33	-44.62
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	9.39	17.12	5.6	1.91	-2.86
Gross Profit, 2 Yr. CAGR %	11.81	22.29	5.28	-2.03	-4.86
EBITDA, 2 Yr. CAGR %	11.8	24.77	4.81	-2.92	-7.04
EBITA, 2 Yr. CAGR %	11.81	24.69	4.86	-2.92	-7.41
EBIT, 2 Yr. CAGR %	11.81	24.69	4.86	-2.92	-7.41
Earnings From Cont. Operations, 2 Yr. CAGR %	65.85	116.88	-37.01	-11.02	63.58
Net Income, 2 Yr. CAGR %	124.29	180.56	-50.13	-10.12	126.7
Diluted EPS Before Extra, 2 Yr. CAGR %	72.07	118.25	-57.35	-8.19	123.41
Normalized Net Income, 2 Yr. CAGR %	40.03	82.48	44.62	72.05	-21.4
Net Property, Plant and Equip., 2 Yr. CAGR %	6.18	12.99	12.11	4.51	-10.84
Accounts Receivable, 2 Yr. CAGR %	-26.42	61.28	34.19	-34.71	-6.47
Total Assets, 2 Yr. CAGR %	7.36	12.97	20.69	3.92	-15.71
Common Equity, 2 Yr. CAGR %	31.48	34.65	22.46	-8.69	-20.23
Tangible Book Value, 2 Yr. CAGR %	37.54	36.82	23.74	-8.89	-21.05
Cash From Operations, 2 Yr. CAGR %	42.23	-1.43	8.98	-8.44	-38.43
Capital Expenditures, 2 Yr. CAGR %	-24.73	13.19	62.12	-54.96	19.76
Levered Free Cash Flow, 2 Yr. CAGR %	96.43	5.47	2.82	78.89	-76.25
Unlevered Free Cash Flow, 2 Yr. CAGR %	52.16	-9.58	-15.95	85.61	-28.66
Dividend Per Share, 2 Yr. CAGR %	0	0	0	-9.63	-32.92
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	5.92	11.07	10.14	5.95	-2.55
Gross Profit, 3 Yr. CAGR %	6.87	14.15	11.69	4.52	-5.52
EBITDA, 3 Yr. CAGR %	7.04	13.6	13.4	3.39	-6.8
EBITA, 3 Yr. CAGR %	7.06	13.65	13.34	3.44	-7.06
EBIT, 3 Yr. CAGR %	7.06	13.65	13.34	3.44	-7.06
Earnings From Cont. Operations, 3 Yr. CAGR %	4.71	77.7	-2.92	17.33	-19.56
Net Income, 3 Yr. CAGR %	30.8	111.05	1.56	14.71	-11.89
Diluted EPS Before Extra, 3 Yr. CAGR %	8.71	56.53	-12.55	2.97	-11.18
Normalized Net Income, 3 Yr. CAGR %	-9.04	41.78	68.59	62.64	-3.85
Net Property, Plant and Equip., 3 Yr. CAGR %	8.29	10.48	10.29	9.32	-5.82
Accounts Receivable, 3 Yr. CAGR %	5.33	42.08	-4.02	31.2	-33.25
Total Assets, 3 Yr. CAGR %	7.66	11.68	15.43	9.28	-5.04
Common Equity, 3 Yr. CAGR %	20.02	36.16	23.03	6.77	-13.22
Tangible Book Value, 3 Yr. CAGR %	26.48	41.15	24.46	7.26	-13.73
Cash From Operations, 3 Yr. CAGR %	27.61	10.23	20.35	-17.82	-11.49
Capital Expenditures, 3 Yr. CAGR %	-48.84	5.36	17.72	-25.18	22.23
Levered Free Cash Flow, 3 Yr. CAGR %	69.29	31.94	25.48	24.82	-54.22
Unlevered Free Cash Flow, 3 Yr. CAGR %	626.28	9.76	0.38	26.04	-14.79
Dividend Per Share, 3 Yr. CAGR %	0	0	0	-6.53	-23.37
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	16.82	11.58	5.79	7.31	4.89
Gross Profit, 5 Yr. CAGR %	18.72	14.1	6.23	7.38	4.75
EBITDA, 5 Yr. CAGR %	20.89	14.04	6.14	6.68	4.74
EBITA, 5 Yr. CAGR %	20.83	14.04	6.17	6.71	4.53
EBIT, 5 Yr. CAGR %	20.83	14.04	6.17	6.71	4.53
Earnings From Cont. Operations, 5 Yr. CAGR %	6.4	29.57	-14.55	34.75	19.61
Net Income, 5 Yr. CAGR %	14.22	35.41	-11.06	50	40.03
Diluted EPS Before Extra, 5 Yr. CAGR %	-10.26	4.48	-25.23	26.45	27.26
Normalized Net Income, 5 Yr. CAGR %	-11.06	44.29	9.5	53.19	24.24
Net Property, Plant and Equip., 5 Yr. CAGR %	16.14	15.68	9.8	8.05	1.3
Accounts Receivable, 5 Yr. CAGR %	19.75	47.51	16.04	4.1	-5.01
Total Assets, 5 Yr. CAGR %	16.7	16.24	12.69	8.51	1.79
Common Equity, 5 Yr. CAGR %	26.02	27.7	20.99	16.04	3.45
Tangible Book Value, 5 Yr. CAGR %	29.4	32.71	25.38	18.48	3.74
Cash From Operations, 5 Yr. CAGR %	32.29	4.72	19.8	2.34	-7.6
Capital Expenditures, 5 Yr. CAGR %	0.35	-8.79	-18.84	-25	18.53
Levered Free Cash Flow, 5 Yr. CAGR %	28.58	13.47	38.68	49.64	-35.82
Unlevered Free Cash Flow, 5 Yr. CAGR %	24.28	8.46	206.53	35.9	-12.44
Dividend Per Share, 5 Yr. CAGR %	-2.11	0	0	-3.97	-14.76